Two retrospective studiesinvestigated the role of SETBP1 mutations in the prognosis of aCML but reached different conclusions, possibly limited by the small number of cases [9, 12]. The gene discussed is SETBP1; the disease is atypical chronic myeloid leukemia, BCR-ABL1 negative.